Human Reproduction, Vol. 16, No. 5, 875-878,
May 2001
© 2001 European Society of Human Reproduction and Embryology
Morbidity of first trimester aspiration termination and the seniority of the surgeon
Department of Obstetrics and Gynaecology, Women's Centre, Oxford Radcliffe Hospitals NHS Trust, Headington, Oxford OX3 9DU, UK
Vacuum aspiration is a safe, acceptable, and efficacious method of first trimester pregnancy termination. The success and complication rates are thought to be partially dependent on operator experience and gestation. We examined this further by studying the outcome of 828 consecutive surgical abortions up to 13 weeks gestation in our hospital. The following outcomes were measured: surgical curettage for presumed retained products of conception; continuing pregnancy; uterine perforation; pelvic sepsis requiring intravenous antibiotics; and blood transfusion required. The complete abortion rate was 94.6% and the rate of continuing pregnancy 0.24%. There was a significant relationship between efficacy and seniority of the surgeon; consultants, senior registrars, registrars, and senior house officers had complete abortion rates of 97.8, 92.8, 94.7, and 88.4% respectively (P = 0.039). Parity did not affect efficacy. Terminations at 1213 weeks gestation were associated with a significantly lower complete abortion rate. The rates of uterine perforation, blood transfusion, pelvic sepsis requiring intravenous antibiotics, and overnight hospital admission were 0.24, 0, 0.97, and 1.69% respectively. Thus, the only significant factors affecting outcome of surgical abortion are grade of operating surgeon or terminations performed at later gestations of 1213 weeks. It is vital that physicians performing surgical terminations are adequately trained.
Key words: abortion/complications/surgical/termination/training
1 To whom correspondence should be addressed at: McGill Reproductive Centre F6, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada. E-mail: tim.child{at}muhc.mcgill.ca
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. M. Bennett, M. Baylson, K. Kalkstein, G. Gillespie, S. L. Bellamy, and J. Fleischman Early Abortion in Family Medicine: Clinical Outcomes Ann. Fam. Med, November 1, 2009; 7(6): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lalitkumar, M. Bygdeman, and K. Gemzell-Danielsson Mid-trimester induced abortion: a review Hum. Reprod. Update, January 1, 2007; 13(1): 37 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Tang, K. H. Mok, and P. C. Ho A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester Hum. Reprod., May 1, 2004; 19(5): 1101 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saxena, S. Salhan, and N. Sarda Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions Hum. Reprod., January 1, 2004; 19(1): 77 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Tang, B.Y. Miao, S. W.H. Lee, and P. C. Ho Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability Hum. Reprod., March 1, 2002; 17(3): 654 - 658. [Abstract] [Full Text] [PDF] |
||||


